
ImpediMed Ltd
ASX:IPD

Balance Sheet
Balance Sheet Decomposition
ImpediMed Ltd
Current Assets | 23.2m |
Cash & Short-Term Investments | 17.7m |
Receivables | 3.6m |
Other Current Assets | 1.9m |
Non-Current Assets | 16m |
Long-Term Investments | 51k |
PP&E | 1.2m |
Intangibles | 14.7m |
Balance Sheet
ImpediMed Ltd
Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
33
|
82
|
55
|
31
|
11
|
20
|
20
|
41
|
46
|
25
|
|
Cash |
33
|
3
|
8
|
3
|
3
|
11
|
8
|
9
|
32
|
6
|
|
Cash Equivalents |
0
|
80
|
47
|
28
|
8
|
9
|
11
|
31
|
14
|
18
|
|
Total Receivables |
1
|
4
|
4
|
4
|
4
|
5
|
5
|
4
|
4
|
3
|
|
Accounts Receivables |
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
2
|
|
Other Receivables |
0
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
1
|
|
Inventory |
2
|
1
|
1
|
2
|
1
|
1
|
0
|
1
|
1
|
1
|
|
Other Current Assets |
0
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
|
Total Current Assets |
35
|
88
|
61
|
38
|
17
|
25
|
26
|
47
|
52
|
29
|
|
PP&E Net |
0
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
2
|
1
|
|
PP&E Gross |
0
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
2
|
1
|
|
Accumulated Depreciation |
1
|
1
|
2
|
2
|
2
|
2
|
2
|
3
|
4
|
4
|
|
Intangible Assets |
0
|
0
|
0
|
1
|
3
|
4
|
5
|
9
|
12
|
13
|
|
Goodwill |
2
|
2
|
2
|
2
|
3
|
3
|
2
|
3
|
3
|
3
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Assets |
2
|
2
|
2
|
2
|
3
|
3
|
2
|
3
|
3
|
3
|
|
Total Assets |
38
N/A
|
91
+139%
|
64
-29%
|
42
-35%
|
23
-46%
|
33
+46%
|
34
+3%
|
59
+72%
|
69
+17%
|
47
-32%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
2
|
2
|
2
|
2
|
2
|
1
|
3
|
1
|
1
|
|
Accrued Liabilities |
2
|
3
|
3
|
4
|
4
|
2
|
6
|
3
|
3
|
2
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
|
Total Current Liabilities |
3
|
5
|
5
|
6
|
7
|
5
|
8
|
7
|
6
|
5
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Total Liabilities |
3
N/A
|
5
+73%
|
6
+4%
|
6
+4%
|
7
+18%
|
6
-16%
|
9
+52%
|
8
-12%
|
8
+3%
|
6
-21%
|
|
Equity | |||||||||||
Common Stock |
147
|
219
|
219
|
220
|
220
|
251
|
267
|
308
|
336
|
336
|
|
Retained Earnings |
116
|
139
|
164
|
189
|
210
|
229
|
247
|
263
|
283
|
304
|
|
Other Equity |
3
|
6
|
4
|
5
|
6
|
6
|
5
|
7
|
8
|
8
|
|
Total Equity |
35
N/A
|
85
+145%
|
59
-31%
|
36
-39%
|
16
-56%
|
27
+73%
|
26
-7%
|
51
+100%
|
61
+19%
|
41
-33%
|
|
Total Liabilities & Equity |
38
N/A
|
91
+139%
|
64
-29%
|
42
-35%
|
23
-46%
|
33
+46%
|
34
+3%
|
59
+72%
|
69
+17%
|
47
-32%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
307
|
392
|
394
|
397
|
398
|
1 002
|
1 492
|
1 778
|
2 018
|
2 023
|